SLGL
Sol-Gel Technologies Ltd. NASDAQ Listed Feb 1, 2018$74.46
+5.83%
vs $70.36
Mkt Cap $209.2M
52w Low $6.96
74.2% of range
52w High $97.97
50d MA $73.09
200d MA $57.24
P/E (TTM)
-33.9x
EV/EBITDA
—
P/B
9.1x
Debt/Equity
0.0x
ROE
-26.9%
P/FCF
754.3x
RSI (14)
50.80
ATR (14)
$5.34
Beta
1.27
50d MA
$73.09
200d MA
$57.24
Avg Volume
34.2K
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
7 Golda Meir Street · Ness Ziona 7403650 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | AMC | -2.86 | -1.31 | +54.2% | 75.28 | +4.6% | -1.9% | -4.7% | +4.7% | -3.0% | +4.0% | — |
| May 12, 2026 | BMO | — | — | — | 69.98 | -2.2% | -4.0% | +8.7% | -6.0% | +5.9% | -6.0% | — |
| Mar 19, 2026 | AMC | 0.39 | -1.07 | -374.4% | 75.34 | -0.4% | +8.5% | -10.7% | -9.3% | +20.9% | -1.2% | — |
| Nov 20, 2025 | AMC | -2.09 | -2.13 | -1.9% | 36.04 | +3.2% | -0.8% | +2.5% | +13.9% | -3.3% | +0.7% | — |
| Aug 15, 2025 | AMC | -0.67 | 4.17 | +722.4% | 15.25 | -0.2% | +1.2% | +4.3% | +10.2% | +3.7% | +40.2% | — |
| Apr 29, 2025 | AMC | -1.10 | -2.10 | -90.9% | 8.12 | +1.0% | +4.8% | -10.7% | +1.8% | -5.7% | -39.5% | — |
| Mar 26, 2025 | AMC | -0.11 | -0.21 | -90.8% | 5.59 | +0.2% | +0.0% | -5.4% | +4.0% | -5.5% | -5.6% | — |
| Nov 15, 2024 | AMC | -0.13 | -0.01 | +92.3% | 5.00 | +13.8% | +3.0% | -5.2% | -11.7% | +2.3% | +7.7% | — |
| Aug 16, 2024 | AMC | -0.20 | 0.07 | +135.0% | 4.20 | +0.0% | +2.6% | +9.0% | -4.5% | +33.6% | +15.8% | — |
| May 20, 2024 | AMC | -0.15 | -0.23 | -53.3% | 7.50 | -6.7% | -6.0% | +13.5% | -1.3% | +1.3% | +0.0% | — |
| Mar 13, 2024 | AMC | -0.16 | -0.17 | -6.2% | 10.60 | -1.9% | +0.0% | -0.9% | -1.0% | +0.0% | -5.6% | — |
| Nov 9, 2023 | AMC | -0.23 | -0.21 | +8.7% | 14.40 | +2.1% | +3.5% | -7.4% | +5.8% | -1.4% | +2.1% | — |
| Aug 10, 2023 | AMC | -0.26 | -0.22 | +15.4% | 31.60 | +9.2% | +1.6% | -9.7% | +5.2% | -8.5% | -2.9% | — |
| May 12, 2023 | BMO | -0.22 | -0.41 | -86.4% | 33.00 | -1.5% | +2.4% | +0.6% | -4.1% | +7.1% | -4.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 | TD Cowen | Initiates | Buy | — | $75.28 | $78.76 | +4.6% | -1.9% | -4.7% | +4.7% | -3.0% | +4.0% |
| Jan 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $69.50 | $69.98 | +0.7% | +3.7% | -12.6% | -8.7% | +1.6% | -1.9% |
| Dec 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $42.16 | $43.11 | +2.3% | +0.0% | +2.4% | +0.8% | -3.9% | +6.4% |
| Oct 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $39.00 | $40.94 | +5.0% | +2.1% | -7.4% | +0.4% | +0.0% | -6.8% |
| Aug 19 | Raymond James | Downgrade | Strong Buy → Outperform | — | $4.31 | $4.41 | +2.3% | +9.0% | -4.5% | +33.6% | +15.8% | -7.1% |
| May 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.00 | $8.26 | +3.2% | -1.2% | +1.3% | +0.0% | +0.6% | -3.1% |
| May 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.50 | $7.00 | -6.7% | -6.0% | +13.5% | -1.3% | +1.3% | +0.0% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.80 | $13.50 | -2.2% | +5.8% | -1.4% | +2.1% | +3.1% | -6.9% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $29.00 | $29.20 | +0.7% | +5.2% | -8.5% | -2.9% | +5.9% | -4.2% |
| Aug 11 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $32.10 | $31.30 | -2.5% | -9.7% | +5.2% | -8.5% | -2.9% | +5.9% |
| Jul 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $39.40 | $40.00 | +1.5% | -1.5% | -7.5% | +0.0% | +1.7% | +0.0% |
| Jul 19 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $30.10 | $31.90 | +6.0% | +12.1% | +9.9% | +6.2% | -1.5% | -7.5% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $33.70 | $34.30 | +1.8% | -0.1% | +3.7% | +1.4% | -3.4% | -2.0% |
| Apr 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $41.50 | $41.00 | -1.2% | -8.3% | +7.0% | -4.2% | -1.8% | +2.6% |
| Mar 14 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $35.00 | $37.50 | +7.1% | +1.7% | -1.7% | +0.0% | -1.7% | +0.2% |
| Feb 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $51.20 | $51.42 | +0.4% | -1.6% | -0.4% | +3.0% | -1.4% | -6.9% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $48.00 | $47.70 | -0.6% | -0.8% | +2.4% | +0.5% | +0.0% | -1.0% |
| Nov 11 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $48.90 | $46.50 | -4.9% | -1.8% | -0.8% | +2.4% | +0.5% | +0.0% |
| Oct 21 | Jefferies | Maintains | Hold → Hold | — | $47.60 | $45.50 | -4.4% | -3.8% | +1.7% | +5.2% | -4.1% | +1.1% |
| Aug 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $59.00 | $64.70 | +9.7% | +2.5% | -0.8% | +1.5% | -1.1% | +0.2% |
| May 16 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $61.80 | $60.40 | -2.3% | +0.0% | +4.4% | +0.0% | -1.9% | -2.1% |
| Apr 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $73.60 | $74.00 | +0.5% | -7.6% | -1.6% | +4.5% | -1.3% | +2.9% |
| Apr 1 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $73.80 | $75.76 | +2.7% | -1.9% | -0.4% | -0.6% | +0.1% | +0.8% |
| Nov 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $89.10 | $89.00 | -0.1% | +0.1% | +2.2% | -1.1% | -5.0% | +0.0% |
| Nov 12 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $90.80 | $90.00 | -0.9% | -1.9% | +0.1% | +2.2% | -1.1% | -5.0% |
| Jul 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $120.00 | $118.80 | -1.0% | +0.8% | -6.9% | -0.2% | -2.1% | -2.2% |
| Jul 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $123.00 | $124.40 | +1.1% | +0.4% | +0.0% | +1.2% | -1.1% | -0.9% |
| Mar 26 | H.C. Wainwright | Maintains | Buy → Buy | — | $75.60 | $75.80 | +0.3% | +1.5% | -2.1% | -7.5% | +1.6% | -8.8% |
| Dec 31 | Jefferies | Maintains | Buy → Buy | — | $146.00 | $178.90 | +22.5% | +17.5% | -8.2% | -0.6% | -1.4% | -4.0% |
| Dec 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $146.00 | $178.90 | +22.5% | +17.5% | -8.2% | -0.6% | -1.4% | -4.0% |
| Dec 31 | H.C. Wainwright | Maintains | Buy → Buy | — | $146.00 | $178.90 | +22.5% | +17.5% | -8.2% | -0.6% | -1.4% | -4.0% |
| Jul 16 | H.C. Wainwright | Maintains | Buy → Buy | — | $69.70 | $75.20 | +7.9% | -3.0% | +3.3% | -2.0% | +0.1% | +1.9% |
| Feb 26 | JMP Securities | Maintains | Market Outperform → Outperform | — | $111.30 | $113.80 | +2.2% | -2.4% | +2.6% | -3.1% | +1.9% | -0.3% |
| Feb 26 | Jefferies | Maintains | Buy → Buy | — | $111.30 | $113.80 | +2.2% | -2.4% | +2.6% | -3.1% | +1.9% | -0.3% |
| Feb 26 | BMO Capital | Maintains | Outperform → Outperform | — | $111.30 | $113.80 | +2.2% | -2.4% | +2.6% | -3.1% | +1.9% | -0.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | Opaleye Management Inc.10% | — | Buy | 1,937 | $66.87 | $130K | 488,437 | +5.88% | +4.63% |
| May 12, 2026 | Opaleye Management Inc.10% | — | Buy | 1,500 | $67.98 | $102K | 486,500 | +5.88% | +4.63% |
No recent filings available.
Institutional (13F) — Top 10
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Opaleye Management Inc. | 453,739 | $19M | Added | Dec 2025 |
| 2 | Phoenix Financial Ltd. | 210,849 | $17M | Reduced | Mar 2026 |
| 3 | Trails Edge Capital Partners, Lp | 85,496 | $7M | New | Mar 2026 |
| 4 | Citadel Advisors Llc | 37,145 | $3M | Added | Mar 2026 |
| 5 | Stonepine Capital Management, Llc | 27,778 | $2M | New | Mar 2026 |
| 6 | Raymond James Financial Inc | 5,733 | $454K | — | Mar 2026 |
| 7 | Morgan Stanley | 9,368 | $395K | Added | Dec 2025 |
| 8 | Hrt Financial Lp | 3,215 | $254K | New | Mar 2026 |
| 9 | Ubs Group Ag | 694 | $55K | Reduced | Mar 2026 |
| 10 | Royal Bank Of Canada | 276 | $22K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 0
All ↗
No N-PORT holders found.
Valuation
Market Cap
$209.2M
Enterprise Value
$183.4M
P/E (TTM)
-33.85x
Forward P/E
—
PEG Ratio
-0.04x
P/B
9.09x
P/S
10.70x
P/FCF
754.31x
EV/EBITDA
—
Shares Out
2.8M
Financials (TTM)
Revenue
$19.4M
Net Income
-$6.1M
EBITDA
-$7.5M
Free Cash Flow
$275K
Op Cash Flow
$322K
EPS Basic
$-2.20
EPS Diluted
$-2.20
EPS Forward
$-6.81
Gross Margin
99.4%
Op Margin
-39.2%
Net Margin
-31.6%
Balance Sheet
Total Assets
$29.9M
Total Liab.
$7.1M
Total Equity
$22.8M
Cash
$24.0M
LT Debt
$0
Book Value/Sh
$8.19
Debt/Equity
0.04x
Current Ratio
4.37
Quick Ratio
4.37
Returns & Growth
ROE
-26.9%
ROA
-20.5%
ROIC
-31.3%
Rev Growth YoY
+68.0%
EPS Growth YoY
-479.0%
Price Returns
2W
+7.5%
1M
-0.2%
3M
-19.4%
6M
+74.1%
12M
+924.4%
Technicals
52W High
$97.97
52W Low
$6.96
50d MA
$73.09
200d MA
$57.24
RSI (14)
50.80
ATR (14)
$5.34
Beta
1.27
Avg Volume
34K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$50.00
High
$50.00
Low
$50.00
Median
$50.00
Data updated apr 27, 2026 1:39am
· Source: financialmodelingprep.com